Fulcrum Therapeutics
FULC
FULC
101 hedge funds and large institutions have $421M invested in Fulcrum Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
+20
Holders Change %
+24.69%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
31
Increased
24
Reduced
21
Closed
11
Calls
$4.61M
Puts
$811K
Net Calls
+$3.8M
Net Calls Change
+$1.94M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$16.5M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
$8.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$5.56M |
| 4 |
Goldman Sachs
New York
|
$5.88M |
| 5 |
Invesco
Atlanta,
Georgia
|
$3.21M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$10.2M |
| 2 |
CAC
Cowen and Company
New York
|
$23.4M |
| 3 |
Millennium Management
New York
|
$2.95M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$3.41M |
| 5 |
RI
RTW Investments
New York
|
$36.9M |
